Issue link: http://www.e-digitaleditions.com/i/880535
Information about devices that may be useful in research and development or manufacturing. Content is provided by companies, with no preference intended. Issue Focus This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Devices Inhalation OctOber 2017 27 Off-the-shelf generic devices Merxin is a device company specializing in off-the-shelf generic devices. Merxin currently supplies three inhalation devices. Its core expertise is in the supply of inhalers, ready to be filled with clients' formulations. Benefits of working with Merxin include ready-to-use devices with no lengthy or costly device design, reduced capital investment, reduced project risk, quick access to a standard DPI device, recognized and popular dry powder inhaler tech- nology, and devices that can be customized to a client's requirements. Merxin UK: +44 1223 787300 www.merxin.com Critical flow controller Copley Scientific has recently launched its new third-generation Critical Flow Controller—the TPK TM 2100—for the testing of dry powder inhalers (DPIs). e TPK TM 2100 is ideally suited to the needs of formu- lators and quality control scientists, setting a new benchmark for the set-up, control and documentation of all parameters associated with the measurement of delivered dose and aerodynamic particle size distribu- tion (APSD) by cascade impaction, in accordance with the United States and European Pharmacopoeias. Copley Scientific UK: +44 1159 616229 www.copleyscientific.com Integrated electronic lockout device Aptar Pharma's e-Lockout is the first EMA-approved, integrated electronic nasal drug delivery device that ensures safe patient compliance by limiting the number of doses available during a 24-hour period. e system's built-in lockout mech- anism prevents the device from being used for a period of time after a pre-defined number of spray actu- ations. e electronic display shows the number of priming strokes, the number of doses remaining and whether the nasal spray is locked or ready for use. The e-Lockout also features a child-resistant cap. Aptar Pharma France: +33 139 17 20 20 www.aptar.com/pharma Photo courtesy of Aptar Pharma